Skip to main content

Iridex Corp

IRIX
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001006045

In the last 90 days, Iridex Corp insiders filed 4 open-market purchases and 0 sales; 29 institutions reported holding it in 13F filings for Q2 2026, worth $2.47M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Iridex Corp changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of IRIX: Q1 2026 compared with Q2 2026
MeasureQ1 2026Of which not filed for Q2 2026Q2 2026Change
Holders25129+5
Shares2.89M1.00M2.17M+278.8K (+14.7%)
Value$2.92M$1.01M$2.47M+$556.6K (+29.1%)

1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (7)

Institutions that held Iridex Corp at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to IRIX in Q2 2026
InstitutionSharesValue% of portfolio
Morgan Stanley305,193$349.4K0.00%
XTX Topco Ltd29,190$33.4K0.00%
Diversify Advisory Services, LLC33,840$30.1K0.00%
Citigroup Inc14,172$16.2K0.00%
Centiva Capital, LP13,920$15.9K0.00%
Caitong International Asset Management Co., Ltd10$110.00%
SBI Securities Co., Ltd.5$60.00%

Sold out (2)

Institutions that held Iridex Corp at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of IRIX in Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Jane Street Group, LLC37,634$38.0K
Two Sigma Securities, LLC10,792$10.9K

Not filed for Q2 2026 yet (1)

Institutions that held Iridex Corp at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IRIX in Q1 2026 that haven't filed for Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Paragon Associates & Paragon Associates II Joint Venture1,000,000$1.01M